Several AASLD leaders and members recently returned from India where AASLD played a vital role in the 27th Annual Conference of the Asian Pacific Association for The Study of the Liver (APASL). The five-day meeting in New Delhi offered AASLD an opportunity to showcase its members’ expertise as well as enrich its global presence through networking with sister organizations around the world.
Robert G. Gish, MD, who participated on the international faculty of the conference, praised the high value of AASLD’s participation.
“The most important event at the APASL meeting was the Wednesday event led by AASLD leaders Anna Lok and Ray Kim who had a full-day symposium on clinical research,” said Dr. Gish. “This allowed clinicians, fellows and trainees to present their data and have a full critique of the key information. Methodology, purpose and conclusions were reviewed in detail with a panel of experts from the Asia-Pacific region as well as the AASLD leadership. I attended this meeting and found it to be extremely high value.”
Dr. Gish said AASLD leadership was key in planning the meeting as well as partnering with APASL’s leadership, notably Shiv K. Sarin, MBBS, and Barjesh C. Sharma, MD, DM, in running the meeting. Dr. Gish also noted that former AASLD President Gyongyi Szabo, MD, PhD, FAASLD, co-chaired a well-received joint symposium on alcoholic liver disease.
The meeting also provided an opportunity for AASLD to discuss future collaborations with APASL.
“The most important issues are communication and developing relationships,” said Dr. Gish. “These open meetings between APASL and AASLD leadership allow specific events to take place that clearly indicate the programs are trying to collaborate to build the best liver care in the world for specific countries, regions and internationally.”
AASLD leadership also met with EASL at the event to discuss upcoming joint programs. Dr. Gish noted that by harmonizing the different organizations’ messages and research results, the liver community overall will benefit through better messaging about the conclusions from current clinical and basic research.